Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2025 14:50 ET | Source: Robbins LLP

AVTR Investor Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Avantor, Inc.

Robbins LLP is Investigating Allegations that Avantor, Inc. (AVTR) Mislead Investors Regarding the Effects of Increased Competition
October 29, 2025 16:06 ET | Source: Robbins LLP

JHX Investor Notice: Robbins LLP Reminds Stockholders of the James Hardie Industries plc Class Action Lawsuit

Robbins LLP is Investigating Allegations that James Hardie Industries plc (JHX) Mislead Investors Regarding Inventory Destocking
October 27, 2025 17:24 ET | Source: Robbins LLP

MoonLake Stockholders with Large Losses are Encouraged to Contact Robbins LLP for Information About the Class Action Against MLTX

A class action alleges MoonLake misled investors about SLK’s Nanobody advantages over BIMZELX. Phase 3 results showed no superiority, sending shares down 8
October 22, 2025 20:56 ET | Source: Robbins LLP

FLR Investors Should Contact Robbins LLP Regarding the Upcoming Lead Plaintiff Deadline in the Fluor Corporation Cass Action

Fluor’s stock plunged 27% after revealing rising project costs, delays, and reduced client spending, exposing its FY 2025 guidance as overstated.
October 22, 2025 20:48 ET | Source: Robbins LLP

CYTK Investors Should Contact Robbins LLP Regarding the Upcoming Lead Plaintiff Deadline in the Cytokinetics, Inc. Class Action

Cytokinetic stock fell after revelations it misled investors about aficamten’s FDA approval timeline and failed to disclose risks delaying the NDA process
October 20, 2025 14:40 ET | Source: Robbins LLP

BAX Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Filed Against Baxter International, Inc.

The Complaint Alleges that Baxter International Inc. (BAX) Mislead Investors Regarding the Safety of its Novum LVP
October 17, 2025 16:52 ET | Source: Robbins LLP

SVRA Lead Plaintiff Deadline (11/7/25) Reminder: Savara Inc. Investors Should Contact Robbins LLP for Information About the Class Action Lawsuit

Savara stock declined 31.7% after the FDA declined to file its MOLBREEVI application, citing incomplete chemistry, manufacturing, and controls information.
October 17, 2025 16:43 ET | Source: Robbins LLP

MLTX Investor Notice: Robbins LLP Reminds Stockholders of the Securities Fraud Class Action Against MoonLake Immunotherapeutics

Robbins LLP is Investigating Allegations that MoonLake Immunotherapeutics (MLTX) Mislead Investors Regarding the Efficacy of its Drug Candidate
October 10, 2025 19:24 ET | Source: Robbins LLP

ATYR Investor Notice: Robbins LLP Reminds Investors of the Securities Fraud Class Action Against aTyr Pharma, Inc.

Robbins LLP is Investigating Allegations that aTyr Pharma, Inc. (ATYR) Mislead Investors Regarding the Efficacy of its Drug Candidate
October 10, 2025 15:49 ET | Source: Robbins LLP

WPP Investor Notice: Robbins LLP Reminds Investors of the Securities Fraud Class Action Lawsuit Against WPP PLC

Robbins LLP is Investigating Allegations that WPP PLC (WPP) Mislead Investors Regarding its Business Prospects